140 related articles for article (PubMed ID: 19721333)
1. Nicorandil improves glomerular injury in rats with mesangioproliferative glomerulonephritis via inhibition of proproliferative and profibrotic growth factors.
Sudo H; Hirata M; Kanada H; Yorozu K; Tashiro Y; Serizawa K; Yogo K; Kataoka M; Moriguchi Y; Ishizuka N
J Pharmacol Sci; 2009 Sep; 111(1):53-9. PubMed ID: 19721333
[TBL] [Abstract][Full Text] [Related]
2. S1P modulator FTY720 limits matrix expansion in acute anti-thy1 mesangioproliferative glomerulonephritis.
Martini S; Krämer S; Loof T; Wang-Rosenke Y; Daig U; Budde K; Neumayer HH; Peters H
Am J Physiol Renal Physiol; 2007 Jun; 292(6):F1761-70. PubMed ID: 17356129
[TBL] [Abstract][Full Text] [Related]
3. Expression and activity of soluble guanylate cyclase in injury and repair of anti-thy1 glomerulonephritis.
Peters H; Wang Y; Loof T; Martini S; Kron S; Krämer S; Neumayer HH
Kidney Int; 2004 Dec; 66(6):2224-36. PubMed ID: 15569311
[TBL] [Abstract][Full Text] [Related]
4. [Preventive effect of multi-glycoside of tripterygium Wilfordii Hook. f. on proteinuria and mesangial injury in experimental mesangial proliferative glomerulonephritis].
Wan YG; Sun W; Zhen YJ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Sep; 25(9):817-21. PubMed ID: 16248246
[TBL] [Abstract][Full Text] [Related]
5. Low-dose mTOR inhibition by rapamycin attenuates progression in anti-thy1-induced chronic glomerulosclerosis of the rat.
Krämer S; Wang-Rosenke Y; Scholl V; Binder E; Loof T; Khadzhynov D; Kawachi H; Shimizu F; Diekmann F; Budde K; Neumayer HH; Peters H
Am J Physiol Renal Physiol; 2008 Feb; 294(2):F440-9. PubMed ID: 18094032
[TBL] [Abstract][Full Text] [Related]
6. Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis.
Nakamura T; Obata J; Kimura H; Ohno S; Yoshida Y; Kawachi H; Shimizu F
Kidney Int; 1999 Mar; 55(3):877-89. PubMed ID: 10027924
[TBL] [Abstract][Full Text] [Related]
7. Tranilast ameliorates experimental mesangial proliferative glomerulonephritis.
Tokuyama H; Kelly DJ; Cox A; Zhang Y; Thai K; Nikolic-Paterson DJ; Gilbert RE
Nephron Exp Nephrol; 2008; 109(1):e1-7. PubMed ID: 18480612
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic mechanism of Saikosaponin-d in anti-Thy1 mAb 1-22-3-induced rat model of glomerulonephritis.
Li P; Gong Y; Zu N; Li Y; Wang B; Shimizu F
Nephron Exp Nephrol; 2005; 101(4):e111-8. PubMed ID: 16103731
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II receptor blockade inhibits acute glomerular injuries with the alteration of receptor expression.
Mii A; Shimizu A; Masuda Y; Ishizaki M; Kawachi H; Iino Y; Katayama Y; Fukuda Y
Lab Invest; 2009 Feb; 89(2):164-77. PubMed ID: 19139720
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis.
Zoja C; Abbate M; Corna D; Capitanio M; Donadelli R; Bruzzi I; Oldroyd S; Benigni A; Remuzzi G
Am J Kidney Dis; 1998 Mar; 31(3):453-63. PubMed ID: 9506682
[TBL] [Abstract][Full Text] [Related]
11. Thrombospondin peptides are potent inhibitors of mesangial and glomerular endothelial cell proliferation in vitro and in vivo.
Hugo CP; Pichler RP; Schulze-Lohoff E; Pröls F; Adler S; Krutsch HC; Murphy-Ullrich JE; Couser WG; Roberts DD; Johnson RJ
Kidney Int; 1999 Jun; 55(6):2236-49. PubMed ID: 10354272
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta receptors in self-limited vs. chronic progressive nephritis in rats.
Watanabe T; Yamamoto T; Ikegaya N; Fujigaki Y; Suzuki H; Togawa A; Fukasawa H; Nagase M; Hishida A
J Pathol; 2002 Nov; 198(3):397-406. PubMed ID: 12375273
[TBL] [Abstract][Full Text] [Related]
13. Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis.
Chen YM; Chien CT; Hu-Tsai MI; Wu KD; Tsai CC; Wu MS; Tsai TJ
Kidney Int; 1999 Sep; 56(3):932-43. PubMed ID: 10469361
[TBL] [Abstract][Full Text] [Related]
14. Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis.
Floege J; Eng E; Young BA; Couser WG; Johnson RJ
Kidney Int; 1993 Feb; 43(2):369-80. PubMed ID: 8441232
[TBL] [Abstract][Full Text] [Related]
15. A novel, dual role of CCN3 in experimental glomerulonephritis: pro-angiogenic and antimesangioproliferative effects.
van Roeyen CR; Boor P; Borkham-Kamphorst E; Rong S; Kunter U; Martin IV; Kaitovic A; Fleckenstein S; Perbal B; Trautwein C; Weiskirchen R; Ostendorf T; Floege J
Am J Pathol; 2012 May; 180(5):1979-90. PubMed ID: 22538190
[TBL] [Abstract][Full Text] [Related]
16. Late angiotensin II receptor blockade in progressive rat mesangioproliferative glomerulonephritis: new insights into mechanisms.
Villa L; Boor P; Konieczny A; Kunter U; van Roeyen CR; Denecke B; Gan L; Neusser MA; Cohen CD; ; Eitner F; Scholl T; Ostendorf T; Floege J
J Pathol; 2013 Apr; 229(5):672-84. PubMed ID: 23192593
[TBL] [Abstract][Full Text] [Related]
17. Role of interleukin-1 in mesangial cell proliferation and matrix deposition in experimental mesangioproliferative nephritis.
Tesch GH; Lan HY; Atkins RC; Nikolic-Paterson DJ
Am J Pathol; 1997 Jul; 151(1):141-50. PubMed ID: 9212740
[TBL] [Abstract][Full Text] [Related]
18. [FTY720 attenuates rat anti-Thy-1 mesangial proliferative glomerulonephritis by inhibition of transforming growth factor β1-connective tissue growth factor pathway].
Jiang JY; Huang XD; Wang Y; Deng AP; Zhou JH
Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):107-11. PubMed ID: 22455887
[TBL] [Abstract][Full Text] [Related]
19. Signal transduction involved in protective effects of 15(R/S)-methyl- lipoxin A(4) on mesangioproliferative nephritis in rats.
Wu SH; Wu XH; Liao PY; Dong L
Prostaglandins Leukot Essent Fatty Acids; 2007 Mar; 76(3):173-80. PubMed ID: 17329090
[TBL] [Abstract][Full Text] [Related]
20. The effects of platelet-derived growth factor antagonism in experimental glomerulonephritis are independent of the transforming growth factor-beta system.
Ostendorf T; Kunter U; van Roeyen C; Dooley S; Janjic N; Ruckman J; Eitner F; Floege J
J Am Soc Nephrol; 2002 Mar; 13(3):658-667. PubMed ID: 11856769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
